Proceedings of the 19th AGM of the company are enclosed herewith.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Limited held its 19th AGM on September 30, 2025, via video conferencing from 11:30 AM to 12:00 PM, chaired by Managing Director Mr. Rajesh Gupta. Seven items of business were transacted, including adoption of the Audited Standalone and Consolidated Financial Statements for FY ended March 31, 2025, re-appointment of Mr. Rajesh Gupta (retiring by rotation), ratification of Cost Auditor remuneration for FY 2025-26, and revision in remuneration for Mr. Rajesh Gupta (MD) and Mrs. Saruchi Gupta (Whole-time Director & CFO). The Company also approved the appointment of Secretarial Auditors and their remuneration. No adverse remarks were made by the Statutory or Secretarial Auditor, and no shareholder queries were raised. Voting results by the Scrutinizer (Mr. Anil Negi) will be disclosed separately.
Routine AGM proceedings with no contentious items or negative observations from auditors. The revision in remuneration for the Managing Director and Whole-time Director signals increased payouts to promoter-directors, while the clean auditor reports offer reassurance to shareholders. Detailed voting outcomes are awaited.